Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, is it Appropriate?

被引:0
|
作者
Christopher W. Mangieri [1 ]
Konstantinos I. Votanopoulos [1 ]
Perry Shen [1 ]
Edward A. Levine [1 ]
机构
[1] Atrium Wake Forest Baptist Medical Center,Division of Surgical Oncology
关键词
D O I
10.1245/s10434-024-16866-6
中图分类号
学科分类号
摘要
引用
收藏
页码:2893 / 2902
页数:9
相关论文
共 50 条
  • [1] Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, Is it Appropriate?
    Mangieri, Chris W.
    Votanopoulos, Konstantinos
    Shen, Perry
    Levine, Edward
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S36 - S36
  • [2] ASO Visual Abstract: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, Is it Appropriate?
    Christopher W. Mangieri
    Konstantinos I. Votanopoulos
    Perry Shen
    Edward A. Levine
    Annals of Surgical Oncology, 2025, 32 (5) : 3694 - 3694
  • [3] Robotic-assisted cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)
    Gabriel, Emmanuel
    Elli, Enrique
    Bagaria, Sanjay
    Wasif, Nabil
    Grotz, Travis
    Stauffer, John
    Kasi, Pashtoon M.
    Asbun, Horacio
    JOURNAL OF ROBOTIC SURGERY, 2019, 13 (01) : 175 - 179
  • [4] Water lavage as an adjunct to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)
    Gabriel, Emmanuel
    Singla, Smit
    Kim, Minhyung
    Fisher, Daniel
    Powers, Colin
    Visioni, Anthony
    Attwood, Kristopher
    Skitzki, Joseph
    AMERICAN JOURNAL OF SURGERY, 2017, 214 (03): : 462 - 467
  • [5] Robotic-assisted cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)
    Emmanuel Gabriel
    Enrique Elli
    Sanjay Bagaria
    Nabil Wasif
    Travis Grotz
    John Stauffer
    Pashtoon M. Kasi
    Horacio Asbun
    Journal of Robotic Surgery, 2019, 13 : 175 - 179
  • [6] ASO Author Reflections: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, a Likely Common Practice but Infrequently Reported
    Christopher W. Mangieri
    Edward A. Levine
    Annals of Surgical Oncology, 2025, 32 (4) : 2932 - 2933
  • [7] Outcome of Icelandic patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) abroad
    Petursdottir, Astriour
    Gunnarsson, Orvar
    Valsdottir, Elsa B.
    LAEKNABLADID, 2020, 106 (7-8): : 344 - 348
  • [8] Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)
    Mangieri, Christopher W.
    Valenzuela, Cristian D.
    Solsky, Ian B.
    Erali, Richard A.
    Votanopoulos, Konstantinos, I
    Shen, Perry
    Levine, Edward A.
    JOURNAL OF SURGICAL ONCOLOGY, 2023, 127 (03) : 450 - 456
  • [9] Impact of Myometrium Invasion on Survival Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)
    Mangieri, Christopher W.
    Valenzuela, Cristian D.
    Solsky, Ian B.
    Erali, Richard A.
    Votanopoulos, Konstantinos I.
    Shen, Perry
    Levine, Edward A.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 470 - 470
  • [10] Impact of insurance status on overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)
    Chokshi, Ravi J.
    Kim, Jin K.
    Patel, Jimmy
    Oliver, Joseph B.
    Mahmoud, Omar
    PLEURA AND PERITONEUM, 2020, 5 (03)